Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

TTUHSC researcher Srinivas Nandana, Ph.D., (left) and co-investigator Manisha Tripathi, Ph.D., received a grant from the U.S. Department of Defense to investigate the role of TBX2 in establishing the ...

Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) ...

Former President Joe Biden, aged 82, has begun radiation therapy for aggressive prostate cancer that has spread to his bones. Experts weigh in on what his prognosis may be and what the treatment path ...

BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

May 4, 2010 (Barcelona, Spain) — Monthly infusions of the bisphosphonate zoledronic acid significantly reduce the risk for bone fractures in men with prostate cancer and malignant bone metastases, ...

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.

The White House has not yet responded to TASS' request for comment on the detection of cancer in the former US leader NEW YORK, May 19. /TASS/. Doctors on Friday diagnosed former US President Joe ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...